Format

Send to

Choose Destination
Heart. 2019 Jun 7. pii: heartjnl-2018-313453. doi: 10.1136/heartjnl-2018-313453. [Epub ahead of print]

Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy.

Author information

1
Department of Obstetrics and Gynaecology, Erasmus MC, Rotterdam, The Netherlands.
2
Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
3
Department of General Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

Abstract

Hypertensive disorders of pregnancy (HDP), such as gestational hypertension and pre-eclampsia, affect up to 10% of all pregnancies. These women have on average a twofold higher risk to develop cardiovascular disease (CVD) later in life as compared with women with normotensive pregnancies. This increased risk might result from an underlying predisposition to CVD, HDP itself or a combination of both. After pregnancy women with HDP show an increased risk of classical cardiovascular risk factors including chronic hypertension, renal dysfunction, dyslipidemia, diabetes and subclinical atherosclerosis. The prevalence and onset of cardiovascular risk factors depends on the severity of the HDP and the coexistence of other pregnancy complications. At present, guidelines addressing postpartum cardiovascular risk assessment for women with HDP show a wide variation in their recommendations. This makes cardiovascular follow-up of women with a previous HDP confusing and non-coherent. Some guidelines advise to initiate cardiovascular follow-up (blood pressure, weight and lifestyle assessment) 6-8 weeks after pregnancy, whereas others recommend to start 6-12 months after pregnancy. Concurrent blood pressure monitoring, lipid and glucose assessment is recommended to be repeated annually to every 5 years until the age of 50 years when women will qualify for cardiovascular risk assessment according to all international cardiovascular prevention guidelines.

KEYWORDS:

cardiac risk factors and prevention; diabetes; hypertension; lipoproteins and hyperlipidemia; pregnancy

Conflict of interest statement

Competing interests: None declared.

Publication type

Publication type

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center